Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: INSP stock price vs FDP: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at FDP's multiple
Needs FDP P/E.
Implied fair value · at INSP's multiple
Needs INSP P/E.
Snapshot Sep 3, 8:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: INSP FY 2025 (ended Dec 31, 2025) · FDP FY 2025 (ended Dec 26, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 94% equity / 6% debt · EV / Revenue 1.78x · EV / EBITDA 24.73x
Capital structure 90% equity / 10% debt · EV / Revenue 0.38x · EV / EBITDA 7.33x
FDP carries the larger enterprise value at $1.65B against $1.63B; FDP trades on the lower EV / Revenue multiple (0.38x vs 1.78x); FDP on the lower EV / EBITDA (7.33x vs 24.73x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Inspire Medical Systems, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
DEL MONTE CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.14x
0.09x
Net debt / EBITDA
Leverage against operating earnings
-2.98x
0.62x
Cash and equivalents
Liquid reserves on the balance sheet
$308.27M
$35.70M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BOSTON SCIENTIFIC CORP
INSP vs BSX
Medtronic plc
INSP vs MDT
ABBOTT LABORATORIES
INSP vs ABT
JOHNSON & JOHNSON
INSP vs JNJ
LivaNova PLC
INSP vs LIVN
CALAVO GROWERS INC
INSP vs CVGW
UNITED NATURAL FOODS INC
INSP vs UNFI
Andersons, Inc.
INSP vs ANDE
CAL-MAINE FOODS INC
INSP vs CALM
$112.36M
$176.20M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
